5PSQ-022 Pharmacological cardioversion in patients with recent-onset atrial fibrillation at emergency department: efficacy and safety of vernakalant

BACKGROUND: Atrial fibrillation (AF) is one of the most common clinically significant cardiac arrhythmias. The management of AF includes conversion to sinus rhythm (SR). Vernakalant is a multi-channel blocker that has effectively converted recent-onset AF and has been well tolerated in placebo-contr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Hosp Pharm
Auteurs principaux: Requejo, C Caballero, Candela, M Onteniente, Muñoz, C Gallego, Candel, M Gil, Valverde, I Salar, Sanz, E Urbieta, Salmerón, P Piñera
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2018
Sujets:
Section 5: Patient safety and quality assurance
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535319/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.376
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires